Quantitative RT-PCR assays of hypoxia-inducible factor-1α, erythropoietin and vascular endothelial growth factor mRNA transcripts in the kidneys with regard to the cause of death in medicolegal autopsy

Legal Medicine

Volumn 8, Issue 5, 2006, Pages 258-263

  Zhao, Dong ^a   Zhu, Bao Li ^a   Ishikawa, Takaki ^a   Li, Dong Ri ^a   Michiue, Tomomi ^a   Maeda, Hitoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cause of death; Erythropoietin; Hypoxia inducible factor 1 ; Kidney; Messenger ribonucleic acid; Postmortem molecular biology; Vascular endothelial growth factor

Indexed keywords

CARBOXYHEMOGLOBIN; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ASPHYXIA; ASPIRATION; AUTOPSY; BLUNT TRAUMA; CADAVER; CAUSE OF DEATH; CONTROLLED STUDY; DIAGNOSTIC VALUE; DROWNING; FATALITY; FEMALE; FIRE; FORENSIC PATHOLOGY; GASTROINTESTINAL HEMORRHAGE; HANGING; HUMAN; ISCHEMIA; KIDNEY; KIDNEY CORTEX; MAJOR CLINICAL STUDY; MALE; NECK; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; STRANGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPHYXIA; CHILD; DROWNING; ERYTHROPOIETIN; FEMALE; FIRES; FORENSIC PATHOLOGY; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUNDS, NONPENETRATING; WOUNDS, PENETRATING;

EID: 33750593660     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.legalmed.2006.05.004     Document Type: Article

References (47)

1. Fandrey J., and Bunn H.F. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood 81 (1993) 617-623
2. Jiang B.H., Semenza G.L., Bauer C., and Marti H.H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271 (1996) 1172-1180
3. Ozaki H., Yu A.Y., Della N., Ozaki K., Luna J.D., Yamada H., Hackett S.F., Okamoto N., Zack D.J., Semenza G.L., and Campochiaro P.A. Hypoxia inducible factor-1α is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40 (1999) 182-189
4. Fandrey J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol 286 (2004) 977-988
5. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., and Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22 (2002) 10291-10301
6. El Awad B., Kreft B., Wolber E.M., Hellwig-Burgel T., Metzen E., Fandrey J., and Jelkmann W. Hypoxia and interleukin-1β stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int 58 (2000) 43-50
7. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 (1996) 4604-4613
8. Sandner P., Gess B., Wolf K., and Kurtz A. Divergent regulation of vascular endothelial growth factor and of erythropoietin gene expression in vivo. Pflugers Arch 431 (1996) 905-912
9. Rosenberger C., Griethe W., Gruber G., Wiesener M., Frei U., Bachmann S., and Eckardt K.U. Cellular responses to hypoxia after renal segmental infarction. Kidney Int 64 (2003) 874-886
10. Juul S.E., Yachnis A.T., and Christensen R.D. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 52 (1998) 235-249
11. Grone H.J., Simon M., and Grone E.F. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 177 (1995) 259-267
12. Villanueva S., Cespedes C., and Vio C.P. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 290 (2006) 861-870
13. Lee S.H., Wolf P.L., Escudero R., Deutsch R., Jamieson S.W., and Thistlethwaite P.A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342 (2000) 626-633
14. Inoue H., Kimura A., and Tuji T. Degradation profile of mRNA in a dead rat body: basic semi-quantification study. Forensic Sci Int 130 (2002) 127-132
15. Ishida K., Zhu B.L., and Maeda H. A quantitative RT-PCR assay of surfactant-associated protein A1 and A2 mRNA transcripts as a diagnostic tool for acute asphyxial death. Legal Med 4 (2002) 7-12
16. Zhao D., Zhu B.L., Ishikawa T., Quan L., Li D.R., Maeda H., and Real-time R.T.-P.C.R. quantitative assays and postmortem degradation profiles of erythropoietin, vascular endothelial growth factor and hypoxia-inducible factor 1 alpha mRNA transcripts in forensic autopsy materials. Legal Med 8 (2006) 132-136
17. Coe J.I. Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14 (1993) 91-117
18. Fekete J.F., and Kerenyi N.A. Postmortem blood sugar and blood urea nitrogen determinations. Can Med Assoc J 92 (1965) 970-973
19. Zhu B.L., Ishikawa T., Michiue T., Li D.R., Zhao D., Quan L., and Maeda H. Evaluation of postmortem urea nitrogen, creatinine and uric acid levels in pericardial fluid in forensic autopsy. Legal Med 7 (2005) 287-292
20. Zhu B.L., Ishida K., Quan L., Taniguchi M., Oritani S., Li D.R., Fujita M.Q., and Maeda H. Postmortem serum uric acid and creatinine levels in relation to the causes of death. Forensic Sci Int 125 (2002) 59-66
21. Zhu B.L., Ishikawa T., Michiue T., Li D.R., Zhao D., Kamikodai Y., Tsuda K., Okazaki S., and Maeda H. Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: Analysis for application in the diagnosis of sudden cardiac death with regard to pathology. Legal Med 8 (2006) 94-101
22. Zhu B.L., Ishikawa T., Michiue T., Li D.R., Zhao D., Oritani S., Kamikodai Y., Tsuda K., Okazaki S., and Maeda H. Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 1. Analysis with special regard to traumatic causes of death. Legal Med 8 (2006) 86-93
23. Ishida K., Zhu B.L., and Maeda H. Novel approach to quantitative reverse transcription PCR assay of mRNA component in autopsy material using the TaqMan fluorogenic detection system: dynamics of pulmonary surfactant apoprotein A. Forensic Sci Int 113 (2000) 127-131
24. Yokomizo R., Matsuzaki S., Uehara S., Murakami T., Yaegashi N., and Okamura K. Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 8 (2002) 441-446
25. Yuan A., Yu C.J., Luh K.T., Chen W.J., Lin F.Y., Kuo S.H., and Yang P.C. Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR. Lab Invest 80 (2000) 1671-1680
26. Maeda H., Fukita K., Oritani S., Nagai K., and Zhu B.L. Evaluation of post-mortem oxymetry in fire victims. Forensic Sci Int 81 (1996) 201-209
27. Maeda H., Fukita K., Oritani S., Ishida K., and Zhu B.L. Evaluation of post-mortem oxymetry with reference to the causes of death. Forensic Sci Int 87 (1997) 201-210
28. Beck I., Ramirez S., Weinmann R., and Caro J. Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem 266 (1991) 15563-15566
29. Liu Y., Cox S.R., Morita T., and Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 77 (1995) 638-643
30. Wiener C.M., Booth G., and Semenza G.L. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225 (1996) 485-488
31. Wang G.L., Jiang B.H., Rue E.A., and Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92 (1995) 5510-5514
32. Beck I., Weinmann R., and Caro J. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 82 (1993) 704-711
33. Semenza G.L., Nejfelt M.K., Chi S.M., and Antonarakis S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88 (1991) 5680-5684
34. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12 (1992) 5447-5454
35. Ran R., Xu H., Lu A., Bernaudin M., and Sharp F.R. Hypoxia preconditioning in the brain. Dev Neurosci 27 (2005) 87-92
36. Kramer B.K., Bucher M., Sandner P., Ittner K.P., Riegger G.A., Ritthaler T., and Kurtz A. Effects of hypoxia on growth factor expression in the rat kidney in vivo. Kidney Int 51 (1997) 444-447
37. Zhu B.L., Ishida K., Taniguchi M., Quan L., Oritani S., Tsuda K., Kamikodai Y., Fujita M.Q., and Maeda H. Possible postmortem serum markers for differentiation between fresh-, saltwater drowning and acute cardiac death: a preliminary investigation. Legal Med 5 (2003) S298-S301
38. Schweda F., Blumberg F.C., Schweda A., Nabel C., Holmer S.R., Riegger G.A., Pfeifer M., and Kramer B.K. Effects of chronic hypoxia on renal PDGF-A, PDGF-B, and VEGF gene expression in rats. Nephron 86 (2000) 161-166
39. Gandini C., Castoldi A.F., Candura S.M., Locatelli C., Butera R., Priori S., and Manzo L. Carbon monoxide cardiotoxicity. J Toxicol Clin Toxicol 39 (2001) 35-44
40. Porta C., Imarisio I., De Amici M., Bonomi L., Paglino C., Biscaldi E., Zimatore M., Sartore-Bianchi A., Danova M., Moratti R., and Riccardi A. Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients. Oncol Rep 13 (2005) 689-695
41. Guyton A.C. Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 19 (1992) 2-8
42. Lohmeier T.E. The sympathetic nervous system and long-term blood pressure regulation. Am J Hypertens 14 (2001) S147-S154
43. Sladen R.N., and Landry D. Renal blood flow regulation, autoregulation, and vasomotor nephropathy. Anesthesiol Clin North Am 18 (2000) 791-807
44. Feliers D., Gorin Y., Ghosh-Choudhury G., Abboud H.E., and Kasinath B.S. Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am J Physiol Renal Physiol 290 (2006) 927-936
45. Qian D., Lin H.Y., Wang H.M., Zhang X., Liu D.L., Li Q.L., and Zhu C. Involvement of ERK1/2 pathway in TGF-beta1-induced VEGF secretion in normal human cytotrophoblast cells. Mol Reprod Dev 68 (2004) 198-204
46. Sanchez-Lopez E., Lopez A.F., Esteban V., Yague S., Egido J., Ruiz-Ortega M., and Alvarez-Arroyo M.V. Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1alpha induction and redox mechanisms in the kidney. Antioxid Redox Signal 7 (2005) 1275-1284
47. Hollenberg N.K. The renin-angiotensin system and sodium homeostasis. J Cardiovasc Pharmacol 6 (1984) S176-S183